Septerna Launches with $100 Million Series A Financing to Expand the Frontier of GPCR-targeted Medicines using the Native Complex™ Platform

Ambys Medicines Appoints Dr. Corinne Foo-Atkins as Chief Strategy Officer

insitro Announces Leadership Team Expansion to Support Advancement of Machine Learning Enabled Drug Discovery and Development Efforts

Pliant Therapeutics Highlights Recent Developments for Lead Program PLN-74809 and Expected 2022 Milestones

Nurix Therapeutics Advances Clinical and Preclinical Pipeline and Outlines 2022 Catalysts